Oncology

Mantle Cell Lymphoma

Advertisment

Expert Perspectives in Mantle Cell Lymphoma to Cover Key Topics in Mantle Cell Lymphoma Treatment

expert perspectives by Anita Kumar, MD; Daniel O. Persky, MD; Julie M. Vose, MD, MBA, FASCO

Overview

Expert Perspectives delivers health care providers with insights from key thought leaders on the latest advancements and current practices in medicine, in a concise and timely format. This issue of Expert Perspectives in Mantle Cell Lymphoma will feature selected topics in Mantle Cell Lymphoma that we hope you will find of value in your clinical practice.

The clinicians who were surveyed selected the following experts and topics.

Community-Selected Experts: 

Anita Kumar, MD

Regional Care Network Medical Site Director
Basking Ridge, NJ
Assistant Attending
Department of Medicine, Lymphoma Service
Memorial Sloan Kettering Cancer Center
New York, NY

Daniel O. Persky, MD

Professor of Medicine
Associate Director of Clinical Investigations
Division of Hematology/Oncology
University of Arizona Cancer Center
University of Arizona College of Medicine
Tucson, AZ

Julie M. Vose, MD, MBA

Neumann M. and Mildred E. Harris Professor
Chief, Division of Oncology/Hematology
Professor of Medicine
University of Nebraska Medical Center
Omaha, NE

Community-Selected Topics: 

Expert Roundtables 

    High-Risk Mantle Cell Lymphoma: Incorporating the Novel Therapies
    Treatment Strategies on the Horizon for Mantle Cell Lymphoma
    Relapsed Mantle Cell Lymphoma: Individualized Treatment Planning
    Chimeric Antigen Receptor T-Cell Therapy for Relapsed Mantle Cell Lymphoma

Clinical Topic Updates

    Allogeneic Stem Cell Transplantation for Mantle Cell Lymphoma in the Current Treatment Era
    Relapse After Frontline Intensive Chemoimmunotherapy for Mantle Cell Lymphoma
    Role of 18F-FDG PET or PET/CT in Mantle Cell Lymphoma
    Mantle Cell Lymphoma: Bridges to Cellular Therapy

 Patient Care Perspectives 

    Reducing Treatment-Related Toxicities in Mantle Cell Lymphoma
    Expectant Monitoring in Mantle Cell Lymphoma
    Patient Selection and Preparation for Chimeric Antigen Receptor T-Cell Therapy in Mantle Cell Lymphoma
    Mantle Cell Lymphoma: Key Questions for Next‐Generation Clinical Trials

Anita Kumar, MD

Regional Care Network Medical Site Director
Basking Ridge, NJ
Assistant Attending
Department of Medicine, Lymphoma Service
Memorial Sloan Kettering Cancer Center
New York, NY

Daniel O. Persky, MD

Professor of Medicine
Associate Director of Clinical Investigations
Division of Hematology/Oncology
University of Arizona Cancer Center
University of Arizona College of Medicine
Tucson, AZ

Julie M. Vose, MD, MBA, FASCO

George and Peggy Payne Distinguished Chair of Oncology
Chief, Oncology/Hematology
Professor of Medicine
University of Nebraska Medical Center
Omaha, NE

Advertisment